HEALTH ECONOMICS
Ruggeri, M., Bellasi, M., Cipriani, F., Molony, D., Bell, C., Russo, D., Di Iorio, B., Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study., <<AMERICAN JOURNAL OF NEPHROLOGY>>, 2014; 28 (5): 593-602. [doi:10.1007/s40620-014-0122-8] [http://hdl.handle.net/10807/63641]
Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study.
Ruggeri, Matteo;
2015
Abstract
HEALTH ECONOMICS
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
